What Biden’s AI executive order means for biotech and healthcare
The president’s recent executive order about artificial intelligence has sweeping ramifications for how medicine intersects with technology.
This week, President Joe Biden issued a historic executive order on artificial intelligence in pursuit of what his administration calls “safe, secure, and trustworthy” AI. The milestone seems imperative given the technology’s rapid evolution and adoption across industries, and a regulatory gauntlet that will ultimately impact millions of Americans. That includes repercussions for the health and biotech industries leveraging AI to innovate as part of a health system that more than 70% of Americans say fails them.